brinzolamide

FDA Drug Profile — Azopt, BRINZOLAMIDE

Drug Details

Generic Name
brinzolamide
Brand Names
Azopt, BRINZOLAMIDE
Application Number
NDA020816
Sponsor
Sandoz Inc
NDC Codes
6
Dosage Forms
SUSPENSION/ DROPS, POWDER
Routes
OPHTHALMIC
Active Ingredients
BRINZOLAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. ( 1 )